NLRP3 and metabolic disease: Abnormal autophagy or mitophagy (the selective autophagic degradation of mitochondria) has been implicated in the aberrant activation of the NLRP3 inflammasome in metabolic diseases such as atherosclerosis and type 2 diabetes [60,61].